山川 裕之

Medicine & Life Sciences

1. Cardiac Myocytes 100%
2. Fibroblasts 63%
3. Heart 43%
4. Regeneration 41%
5. Induced Pluripotent Stem Cells 36%
6. Fabry Disease 29%
7. Stem Cells 29%
8. Regenerative Medicine 28%
9. Ryanodine Receptor Calcium Release Channel 26%
10. Pluripotent Stem Cells 25%
11. Myocardial Infarction 19%
12. Receptors, Prostaglandin E, EP4 Subtype 18%
13. Complement Factor D 17%
14. Fibrosis 16%
15. Up-Regulation 15%
16. Vascular Endothelial Growth Factor A 15%
17. Heart Failure 15%
18. Monomeric GTP-Binding Proteins 14%
19. Takotsubo Cardiomyopathy 14%
20. Sendai virus 14%
21. Actomyosin 14%
22. Long QT Syndrome 14%
23. Caloric Restriction 13%
24. Complement C3 13%
25. Fibroblast Growth Factors 13%
26. Cellular Senescence 12%
27. Cyclic AMP-Dependent Protein Kinases 12%
28. Neuropeptide Y 12%
29. Transgenes 12%
30. Doxycycline 12%
31. Cause of Death 12%
32. Heart Diseases 12%
33. Genes 12%
34. Stem Cell Research 12%
35. Retroviridae 11%
36. Myocardium 11%
37. Diclofenac 11%
38. Skeletal Muscle 11%
39. Tetracycline 11%
40. Cyclooxygenase 2 11%
41. Thyroid Hormones 10%
42. Multiple Myeloma 10%
43. Dinoprostone 10%
44. RNA Interference 10%
45. Infarction 10%
46. Integrins 10%
47. Wounds and Injuries 10%
48. Transgenic Mice 10%
49. Drosophila 10%
50. Phosphorylation 10%